Table 4.
Drug-related toxicity.
| Adverse event | TACE-sorafenib-ablation (n=22) | TACE-sorafenib (n=28) | ||
|---|---|---|---|---|
| Any grade | Grade 3 | Any grade | Grade 3 | |
| Hand-foot reaction | 19 (86.4%) | 1 (4.5%) | 24 (85.7%) | 1 (3.6%) |
| Rash | 8 (36.4%) | 0 | 6 (21.4%) | 0 |
| Diarrhea | 4 (18.2%) | 0 | 10 (35.7%) | 0 |
| Hypertension | 3 (13.6%) | 0 | 1 (3.6%) | 0 |
| Voice changes | 1 (4.5%) | 0 | 2 (7.1%) | 0 |
| Bleeding | 0 | 0 | 1 (3.6%) | 1 (3.6%) |
| Liver dysfunction | 0 | 0 | 1 (3.6%) | 1 (3.6%) |
| Alopecia | 7 (31.8%) | 0 | 11(39.3%) | 0 |